Executive summary: American Academy of Dermatology guidelines of care for the management of atopic dermatitis in adults with topical therapies-Reference-Cited by-同舟云学术

Executive summary: American Academy of Dermatology guidelines of care for the management of atopic dermatitis in adults with topical therapies

Published:2023-07 Issue:1 Volume:89 Page:128-129
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Sidbury Robert,Alikhan Ali,Bercovitch Lionel,Cohen David E.,Darr Jennifer M.,Drucker Aaron M.,Eichenfield Lawrence F.,Frazer-Green Lindsy,Paller Amy S.,Schwarzenberger Kathryn,Silverberg Jonathan I.,Singh Anne Marie,Wu Peggy A.,Davis Dawn M.R.

Funder

American Academy of Dermatology

Publisher

Elsevier BV

Subject

Dermatology

Reference1 articles.

1. Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies;Eichenfield;J Am Acad Dermatol,2014

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting mitochondrial dysfunction in atopic dermatitis with trilinolein: A triacylglycerol from the medicinal plant Cannabis fructus;Phytomedicine;2024-09

2. Successful treatment of severe atopic dermatitis and alopecia universalis with upadacitinib in a 29-year-old male patient;Journal of Allergy and Clinical Immunology: Global;2024-08

3. Ruxolitinib Cream in Adolescents/Adults with Atopic Dermatitis Meeting Severity Thresholds for Systemic Therapy: Exploratory Analysis of Pooled Results from Two Phase 3 Studies;Dermatology and Therapy;2024-07-12

4. Use of Topical Corticosteroids in the Treatment of Noninfectious Inflammatory Dermatoses of the Scalp: A Survey of Practicing Dermatologists and Dermatology Residents Using Delphi Methodology;Clinical, Cosmetic and Investigational Dermatology;2024-03

5. Clinically relevant improvements in adults and adolescents with atopic dermatitis who did not achieve Investigator's Global Assessment treatment success following 8 weeks of ruxolitinib cream monotherapy;The Journal of Dermatology;2023-10-13